Phase 2 Study of Combination Tivozanib and Nivolumab in Advanced Non-Clear Cell Renal Cell Carcinoma

Condition:   Renal Cell Carcinoma Interventions:   Drug: Tivozanib;   Drug: Nivolumab Sponsors:   M.D. Anderson Cancer Center;   AVEO Pharmaceuticals, Inc. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials